| HOME >> BIOLOGY >> TECHNOLOGY |
The outside laboratories that have been conducting research for us have been performing excellent work and we appreciate the relationships that we have developed, maintain, and may expand as we seek new and experienced partners in our development efforts (most recently VaxGen and Uluru).
I am looking forward to announcing our next updates, results, conferences, etc. The relationships we are forging today based on our current data as well as anticipation of future data are very exciting and we hope to be able to discuss formalizing them over the next few months. Keep in touch with our updates by viewing our website http://www.immuneregen.com. We are available to answer your queries and hope that you will send an email to me at mwilhelm@immuneregen.com or to Dr. Siegel, Senior Director of Product Development and Regulatory Affairs hsiegel@immuneregen.com. We are happy to answer your corporate and scientific questions. Keep in mind that our responses can only reflect that information that is already publicly available.
Best regards,
Michael K. Wilhelm
Chief Executive Officer
ImmuneRegen BioSciences, Inc.
IR BioSciences Holdings, Inc.
310-477-9500
SOURCE ImmuneRegen BioSciences, Inc.![]() Copyright©2007 PR Newswire. |